FR3021224A1 - PHYTOMEDICAMENT FOR HIV - Google Patents
PHYTOMEDICAMENT FOR HIV Download PDFInfo
- Publication number
- FR3021224A1 FR3021224A1 FR1401199A FR1401199A FR3021224A1 FR 3021224 A1 FR3021224 A1 FR 3021224A1 FR 1401199 A FR1401199 A FR 1401199A FR 1401199 A FR1401199 A FR 1401199A FR 3021224 A1 FR3021224 A1 FR 3021224A1
- Authority
- FR
- France
- Prior art keywords
- plants
- roots
- pharmaceutical compound
- capsules
- genus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Composé pharmaceutique solide ou liquide bien toléré est une association de plantes africaines ayant des actions synergiques pour améliorer la santé des personnes vivants avec le VIH, il s'agit d'une association de cinq plantes que sont : racines d'Imperata cylindrica, racines et feuilles de moringa oleifeira, de racines de paspalum conjugatum, et racines de Fagara xanthoxyloïdes et de racines de cyathea aethiopica. Ce produit est obtenu en séchant dans un premier temps ces différentes racines et graines à l'ombre. Ensuite elles sont broyées, tamisées de façon à obtenir une poudre fine. Les différentes poudres mélangées et réparties dans des gélules vides préalablement bien nettoyées et mises dans de petits flacons de 20, 50 ou 100 gélules. Composé pharmaceutique solide peut être plus concentré, puis complétée par un solvant. Ensuite chaque flacon est placé dans un appareil approprié pendant une semaine environ. On procède au mélange des poudres enrichies obtenues à l'aide d'un mélangeur-malaxeur. Ces gélules peuvent même être mises sous blister. La forme liquide Les différentes poudres sont pesées et prises en quantités appropriées, le mélange est effectué dans un grand récipient, puis il est ajouté un solvant. Le Composé pharmaceutique solide et liquide a une action antivirale, antibactérienne et stimulant du système immunitaire.Well tolerated solid or liquid pharmaceutical compound is a combination of African plants with synergistic actions to improve the health of people living with HIV, it is a combination of five plants that are: Imperata cylindrica roots, roots and leaves of moringa oleifeira, roots of paspalum conjugatum, and xanthoxyloid Fagara roots and roots of cyathea aethiopica. This product is obtained by first drying these different roots and seeds in the shade. Then they are crushed, sieved to obtain a fine powder. The various powders are mixed and distributed in empty capsules that have been thoroughly cleaned and put in small bottles of 20, 50 or 100 capsules. Solid pharmaceutical compound may be more concentrated and then supplemented with a solvent. Then each vial is placed in a suitable device for about a week. The enriched powders obtained are mixed using a mixer-mixer. These capsules can even be blistered. The liquid form The different powders are weighed and taken in appropriate quantities, the mixture is made in a large container, and then a solvent is added. The solid and liquid pharmaceutical compound has an antiviral, antibacterial and immune system stimulating action.
Description
La présente invention concerne un phytomédicament solide ou liquide utile pour la santé des personnes vivantes avec le VIH, agissant comme un antiviral puissant, un stimulant du système immunitaire ainsi qu'un antibactérien contre les maladies opportunistes. Le VIH est une affection virale qui crée un déficit important dans le système immunitaire ouvrant la porte à toutes sortes infections opportunistes. Aujourd'hui les Antirétroviraux constituent un arsenal important dans le dispositif de prise en charge du VIH. A côté de ces médicaments, la phytothérapie occupe une place de choix et permet en Afrique à ceux-là qui n'ont pas accès aux Antirétroviraux de s'en sortir.The present invention relates to a solid or liquid phytomedicine useful for the health of persons living with HIV, acting as a powerful antiviral, an immune system stimulant and an antibacterial against opportunistic diseases. HIV is a viral disease that creates a significant deficit in the immune system that opens the door to all sorts of opportunistic infections. Today antiretrovirals are an important arsenal in the HIV management system. Alongside these drugs, phytotherapy occupies a place of choice and allows those in Africa who do not have access to antiretrovirals to get by.
Les plantes médicinales utilisées pour diminuer les troubles liés à l'immunodéficience acquise sont nombreuses. Les populations qui disposent dans leur patrimoine culturel des plantes médicinales utiles pour le traitement des troubles liés à la déficience immunitaire emploient ces dernières sans aucune rigueur scientifique. Cela ne les protège pas totalement ni contre la maladie ni d'autres problèmes de Santé (atteinte des reins, de la rate, effet toxique) La présente invention permet de remédier à la baisse de l'immunité et de lutter efficacement contre les maladies opportunistes. Le Composé pharmaceutique solide ou liquide, un médicament à base de plantes rigoureusement sélectionnées et testées a un double rôle à savoir, améliorer le système immunitaire et lutter efficacement contre les maladies opportunistes.The medicinal plants used to reduce the disorders related to the acquired immunodeficiency are numerous. People who have medicinal plants in their cultural heritage that are useful for the treatment of disorders linked to immune deficiency use the latter without any scientific rigor. This does not protect them completely or against the disease or other health problems (kidney, spleen, toxic effect) The present invention makes it possible to remedy the decline in immunity and effectively fight against opportunistic diseases . The solid or liquid pharmaceutical compound, a rigorously selected and tested herbal medicine has a dual role namely, to improve the immune system and effectively fight against opportunistic diseases.
Le Composé pharmaceutique solide ou liquide qui vient résoudre ces différents problèmes et complications, se veut bien un médicament efficace dans l'amélioration du système immunitaire mais est également utilisé efficacement à titre curatif lorsque les maladies opportunistes sont installées. Selon un premier aspect de l'invention, il est sous forme de gélule comprenant une association de quatre plantes à savoir : Extraits totaux de plantes de la famille des Graminées, du genre Imperata, plus particulièrement de l'espèce Imperata cylindrica, Extraits totaux de plantes de la famille des graminées d'un genre paspalum, plus particulièrement de l'espèce paspalum conjugatum, Extraits totaux de plantes de la famille moringacées, d'un genre moringa, plus particulièrement de l'espèce moringa oléifeira. Extraits totaux de plantes de la famille des rutacées d'un genre fagara, plus particulièrement de l'espèce fagara Xanthoxyloïdes, Extraits totaux de plantes de la famille des ptéridophytes d'un genre cyathea, plus particulièrement de l'espèce cyathea aethiopica. La Forme Solide Ainsi, sous forme solide, le composé pharmaceutique peut être obtenu en séchant dans un premier temps ces différentes racines et graines à l'ombre. Ensuite elles sont broyées, tamisées de façon à obtenir une poudre fine. Les différentes poudres sont pesées, prises dans des proportions définies, elles sont mélangées et réparties dans des gélules vides préalablement bien conservées et mises dans de petits flacons de 20, 50 ou 100 gélules. Le phytomédicament solide peut selon une autre méthode scientifique avoir un aspect plus concentré : pour ce faire il faut peser chaque poudre à mettre dans un solvant approprié. Ensuite chaque flacon est placé dans un appareil appelé « rotavapor », que l'on laisse tourner pendant une semaine environ. Il sert à l'enrichissement et à la concentration des principes actifs. Ce qui permet de rendre plus performant le produit. On procède au mélange avec un appareil appelé mélangeur-malaxeur pour un mélange plus rigoureux et on répartit les poudres dans les gélules. Ces gélules peuvent être mises sous blister et on peut utiliser à ce niveau des excipients. La forme liquide Selon un autre aspect de l'invention, il est fourni une solution du composé ; les différentes poudres prises en quantités appropriées, le mélange est effectué dans un grand récipient en inox, puis il est ajouté de l'alcool éthylique à 40° ou du Gin Royal à raison de 100g de poudre pour un litre d'alcool. Le mélange est fait à l'aide de spatule ou de louche et est filtré puis réparti dans les flacons. Le Composé pharmaceutique solide et liquide a une action antivirale, antibactérienne et stimulante du système immunitaire. INDICATIONS : Améliore la santé des Personne vivants avec le VIH POSOLOGIE Gélules : 2 gélules matin et soir au milieu des repas Solution : une cuillérée à soupe matin et soir au milieu des repas Précaution d'emploi : Insuffisance rénale PRESENTATION En gélules boite de 50, de 100 et en boite de 20.The solid or liquid pharmaceutical compound that comes to solve these various problems and complications, is an effective drug in the improvement of the immune system but is also used effectively for healing when opportunistic diseases are installed. According to a first aspect of the invention, it is in the form of a capsule comprising an association of four plants, namely: Total extracts of plants of the family Gramineae, of the genus Imperata, more particularly of the species Imperata cylindrica, total extracts of plants of the family of grasses of a genus paspalum, more particularly of the species paspalum conjugatum, total extracts of plants of the moringaceae family, of a moringa genus, more particularly of the species moringa oléifeira. Total extracts of plants of the rutaceae family of a fagara genus, more particularly of the fagara Xanthoxyloïdes species, total extracts of plants of the pteridophyte family of genus cyathea, more particularly of the species cyathea aethiopica. Solid Form Thus, in solid form, the pharmaceutical compound can be obtained by drying these different roots and seeds in the first place in the shade. Then they are crushed, sieved to obtain a fine powder. The different powders are weighed, taken in defined proportions, they are mixed and distributed in empty capsules previously well preserved and put in small bottles of 20, 50 or 100 capsules. The solid phytomedicament can according to another scientific method have a more concentrated appearance: to do this we must weigh each powder to put in a suitable solvent. Then each bottle is placed in a device called "rotavapor", which is allowed to rotate for a week or so. It is used for the enrichment and concentration of active ingredients. This makes the product more efficient. Mixing is carried out with an apparatus called mixer-kneader for a more rigorous mixture and the powders are distributed in the capsules. These capsules may be blistered and excipients may be used at this level. The liquid form According to another aspect of the invention, there is provided a solution of the compound; the various powders taken in appropriate quantities, the mixture is made in a large stainless steel container, then is added 40 ° ethyl alcohol or Royal Gin at a rate of 100g of powder per liter of alcohol. The mixture is made using a spatula or ladle and is filtered and then distributed in the flasks. The solid and liquid pharmaceutical compound has an antiviral, antibacterial and stimulating action of the immune system. INDICATIONS: Improves the health of people living with HIV DOSAGE Capsules: 2 capsules morning and evening in the middle of meals Solution: one tablespoon morning and evening in the middle of meals Precaution for use: Kidney failure PRESENTATION In capsules box of 50, of 100 and in box of 20.
En solution flacon de 1litre et en solution flacon de 250 ml.In 1 liter bottle solution and in 250 ml bottle.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1401199A FR3021224B1 (en) | 2014-05-26 | 2014-05-26 | PHYTOMEDICAMENT FOR HIV |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1401199A FR3021224B1 (en) | 2014-05-26 | 2014-05-26 | PHYTOMEDICAMENT FOR HIV |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3021224A1 true FR3021224A1 (en) | 2015-11-27 |
FR3021224B1 FR3021224B1 (en) | 2017-11-17 |
Family
ID=52423735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1401199A Expired - Fee Related FR3021224B1 (en) | 2014-05-26 | 2014-05-26 | PHYTOMEDICAMENT FOR HIV |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3021224B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108355081A (en) * | 2018-03-27 | 2018-08-03 | 江苏娘亲亲母婴健康管理有限公司 | A kind of Chinese medicine preparation of immune promotion |
FR3080283A1 (en) * | 2018-04-19 | 2019-10-25 | Henri Charles Ainadou | PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST FIEVRE LASSA |
FR3080280A1 (en) * | 2018-04-19 | 2019-10-25 | Henri Charles Ainadou | PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST EBOLA FEVER |
FR3080281A1 (en) * | 2018-04-19 | 2019-10-25 | Henri Charles Ainadou | PHYTOMEDICAMENT WITH ANTIVIRAL ACTIVITY AGAINST VIRAL HEPATITIS |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2855056A1 (en) * | 2002-01-18 | 2004-11-26 | Fagla Jerome Medegan | Herbal medicament, e.g. for treating sickle cell anemia or AIDS, containing extracts of Fagara xanthyloxyloides and Securidaca longepedonculata and/or Uvaria chamae |
FR2859107A1 (en) * | 2003-08-26 | 2005-03-04 | Oyoubi Pierre Pyebi | USE OF THE EXTRACTS OF A GRAMINEE, A RUTACEE AND A PIERIDOPHYTE IN A PHARMACEUTICAL COMPOSITION WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL ACTIVITY AND ALSO INTENDED TO STIMULATE IMMUNE DEFENSES |
-
2014
- 2014-05-26 FR FR1401199A patent/FR3021224B1/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2855056A1 (en) * | 2002-01-18 | 2004-11-26 | Fagla Jerome Medegan | Herbal medicament, e.g. for treating sickle cell anemia or AIDS, containing extracts of Fagara xanthyloxyloides and Securidaca longepedonculata and/or Uvaria chamae |
FR2859107A1 (en) * | 2003-08-26 | 2005-03-04 | Oyoubi Pierre Pyebi | USE OF THE EXTRACTS OF A GRAMINEE, A RUTACEE AND A PIERIDOPHYTE IN A PHARMACEUTICAL COMPOSITION WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL ACTIVITY AND ALSO INTENDED TO STIMULATE IMMUNE DEFENSES |
Non-Patent Citations (5)
Title |
---|
ANONYMOUS: "Moringa Leaves Powder Preparation", INTERNET CITATION, 10 March 2013 (2013-03-10), pages 1 - 5, XP002715420, Retrieved from the Internet <URL:http://miracletrees.org/moringa_leaves_powder.html> [retrieved on 20131024] * |
DATABASE CAPLUS, [online] 15 April 2009 (2009-04-15), SHANG ZHENG: "MEDICATED TEA COMPRISING RADIX PUERARIAE, LALANG GRASS RHIZOMA AND RHIZOMA PHRAGMITIS, AND ITS PREPARATION METHOD", XP002670672, retrieved from CAPLUS Database accession no. 2009-460408 2009-460408 * |
J. M. CALDERON-MONTANO ET AL: "A Review on the Dietary Flavonoid Kaempferol", MINI-REVIEWS IN MEDICINAL CHEMISTRY, 1 April 2011 (2011-04-01), pages 298 - 344, XP055093966, Retrieved from the Internet <URL:http://www.eurekaselect.com/openurl/content.php?genre=article&issn=13895575&volume=11&issue=4&spage=298> DOI: 10.2174/138955711795305335 * |
MONERA TG ET AL: "Moringa oleifera supplementation by patients on antiretroviral therapy", JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, BIOMED CENTRAL LTD, LONDON, UK, vol. 13, no. Suppl 4, 8 November 2010 (2010-11-08), pages P188, XP021084515, ISSN: 1758-2652, DOI: 10.1186/1758-2652-13-S4-P188 * |
POPOOLA JACOB O ET AL: "Local knowledge, use pattern and geographical distribution ofMoringa oleiferaLam. (Moringaceae) in Nigeria", JOURNAL OF ETHNOPHARMACOLOGY, vol. 150, no. 2, 2 October 2013 (2013-10-02), pages 682 - 691, XP028765969, ISSN: 0378-8741, DOI: 10.1016/J.JEP.2013.09.043 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108355081A (en) * | 2018-03-27 | 2018-08-03 | 江苏娘亲亲母婴健康管理有限公司 | A kind of Chinese medicine preparation of immune promotion |
FR3080283A1 (en) * | 2018-04-19 | 2019-10-25 | Henri Charles Ainadou | PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST FIEVRE LASSA |
FR3080280A1 (en) * | 2018-04-19 | 2019-10-25 | Henri Charles Ainadou | PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY AGAINST EBOLA FEVER |
FR3080281A1 (en) * | 2018-04-19 | 2019-10-25 | Henri Charles Ainadou | PHYTOMEDICAMENT WITH ANTIVIRAL ACTIVITY AGAINST VIRAL HEPATITIS |
Also Published As
Publication number | Publication date |
---|---|
FR3021224B1 (en) | 2017-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Okigbo et al. | An appraisal of phytomedicine in Africa | |
George | Concerns regarding the safety and toxicity of medicinal plants-An overview | |
Germano et al. | A pilot study on bioactive constituents and analgesic effects of MyrLiq®, a Commiphora myrrha extract with a high furanodiene content | |
Rahmatullah et al. | Medicinal plants used by various tribes of Bangladesh for treatment of malaria | |
US8535737B2 (en) | Composition with extracts from olive leaf, yarrow and rosemary for treating human diseases and conditions | |
Imanirampa et al. | Antifungal activity of Cleome gynandra L. aerial parts for topical treatment of Tinea capitis: an in vitro evaluation | |
FR3021224A1 (en) | PHYTOMEDICAMENT FOR HIV | |
Ionescu | Are herbal products an alternative to antibiotics? | |
Al Mamun et al. | Flavonoids isolated from Tridax procumbens (TPF) inhibit osteoclasts differentiation and bone resorption | |
Matraszek-Gawron et al. | Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus L. | |
Larit et al. | Therapeutics to treat psychiatric and neurological disorders: A promising perspective from algerian traditional medicine | |
Quinto-Ortiz et al. | Pharmacological interaction of quercetin derivatives of tilia americana and clinical drugs in experimental fibromyalgia | |
Lee et al. | Dietary supplementation with Ceriporia lacerata improves learning and memory in a scopolamine-induced amnesia mouse model | |
Denis-Esdras et al. | Ethnobotany study of Loranthaceae, hemiparasitic plants used in traditional medicine by population, in the Sud-Comoé region (Côte d’Ivoire) | |
Natural Standard | Natural Standard Herb & Supplement Guide-E-Book: An Evidence-Based Reference | |
Da Silva et al. | Croton grewioides Baill.(Euphorbiaceae) shows antidiarrheal activity in mice | |
Izah et al. | Research needs of medicinal plants used in the management and treatment of some diseases caused by microorganisms | |
FR3080282A1 (en) | PHYTOMEDICAMENT WITH ANTIBACTERIAL ACTIVITY AGAINST GASTRODUODENAL ULCER AND CROHN'S DISEASE | |
Koffi et al. | Evaluation of Picralima nitida acute toxicity in the mouse | |
Aljeboory et al. | Loranthus europaeus is an alternative medicine in treatment of cyst and mouth inflammation resulted from chemotherapy of breast cancer | |
Meesakul et al. | Hawaiian Plants with Beneficial Effects on Sleep, Anxiety, and Mood, etc. | |
RU2315616C1 (en) | Agent for treatment and prophylaxis of cardiovascular diseases | |
Madhu et al. | Anti-diabetic, anti-cancer activity and associated toxicity of Leucas aspera extract in Wistar albino rats | |
FR3021222A1 (en) | PHYTOMEDICAMENT AGAINST MALARIA | |
Rasoanaivo et al. | Using appropriate methodology and technology for research and development of African traditional medicines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20151127 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
ST | Notification of lapse |
Effective date: 20220105 |